Grand Pharmaceutical Group (0512.HK) Earnings Analysis
Grand Pharmaceutical Group (0512.HK) next reports earnings on 2026-08-12. Trailing P/E 15.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 0512.HK next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
0512.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-19 | 0.3338 HKD | n/a | n/a | n/a |
| 2025-03-12 | 0.26 HKD | n/a | n/a | n/a |
| 2024-08-19 | 0.4441 HKD | n/a | n/a | n/a |
0512.HK valuation and analyst view
| Trailing P/E | 15.04 |
|---|---|
| Trailing EPS | 0.35434 HKD |
| Price / book | 1.08 |
| Dividend yield | 3.21% |
| Market cap | 18.63B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Grand Pharmaceutical Group (0512.HK)'s next earnings date?
Grand Pharmaceutical Group is next scheduled to report on 2026-08-12.
Did 0512.HK beat earnings last quarter?
Consensus estimate data was not available for 0512.HK's 2025-08-19 report.
What is 0512.HK's current P/E ratio and EPS?
0512.HK trades at a trailing P/E of 15.04 on trailing EPS of 0.35434213631358835 HKD.
What do analysts rate 0512.HK?
0512.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.